DK0721782T3 - Influenzavaccine indeholdende pertussistoksin - Google Patents

Influenzavaccine indeholdende pertussistoksin

Info

Publication number: DK0721782T3
Authority: DK; Denmark
Prior art keywords: amino acid; pertussis toxin; influenza vaccine; vaccine containing; substituted
Prior art date: 1995-01-16

Application number

DK96300197T

Other languages

English (en)

Inventor

Mark Roberts

Original Assignee

Medeva Europ Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-16

Filing date

1996-01-09

Publication date

2000-12-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0721782(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-01-09 Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd

2000-12-18 Application granted granted Critical

2000-12-18 Publication of DK0721782T3 publication Critical patent/DK0721782T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

DK96300197T 1995-01-16 1996-01-09 Influenzavaccine indeholdende pertussistoksin DK0721782T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9500788.6A GB9500788D0 (en)	1995-01-16	1995-01-16	Vaccine compositions

Publications (1)

Publication Number	Publication Date
DK0721782T3 true DK0721782T3 (da)	2000-12-18

Family

ID=10768080

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96300197T DK0721782T3 (da)	1995-01-16	1996-01-09	Influenzavaccine indeholdende pertussistoksin

Country Status (8)

Country	Link
EP (1)	EP0721782B1 (da)
AT (1)	ATE195427T1 (da)
DE (1)	DE69609739T2 (da)
DK (1)	DK0721782T3 (da)
ES (1)	ES2150631T3 (da)
GB (1)	GB9500788D0 (da)
GR (1)	GR3034773T3 (da)
PT (1)	PT721782E (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2164148C1 (ru) *	2000-08-09	2001-03-20	Петров Рэм Викторович	Вакцина против вируса гриппа и способ ее получения
ATE488248T1 (de)	2004-09-09	2010-12-15	Novartis Vaccines & Diagnostic	Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
JP2008519042A (ja)	2004-11-03	2008-06-05	ノバルティスヴァクシンズアンドダイアグノスティクス，インコーポレイテッド	インフルエンザワクチン接種
TW201103980A (en) *	2009-07-08	2011-02-01	Abbott Biologicals Bv	Viral vaccine and use thereof
EP2614163B1 (en)	2010-09-07	2016-01-06	Novartis AG	Generic assays for detection of mammalian reovirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03135923A (ja) *	1989-10-20	1991-06-10	Chemo Sero Therapeut Res Inst	百日咳毒素ｂオリゴマーの構成サブユニットを含有する経鼻接種ワクチン
IT1248735B (it) *	1990-06-21	1995-01-26	Sclavo Spa	Vaccini acellulari contro la pertosse
US20030072774A1 (en) *	1994-06-10	2003-04-17	Diane M. Gajewczyk	Proteinaceous adjuvants

1995
- 1995-01-16 GB GBGB9500788.6A patent/GB9500788D0/en active Pending
1996
- 1996-01-09 DE DE69609739T patent/DE69609739T2/de not_active Expired - Fee Related
- 1996-01-09 EP EP96300197A patent/EP0721782B1/en not_active Expired - Lifetime
- 1996-01-09 ES ES96300197T patent/ES2150631T3/es not_active Expired - Lifetime
- 1996-01-09 PT PT96300197T patent/PT721782E/pt unknown
- 1996-01-09 AT AT96300197T patent/ATE195427T1/de not_active IP Right Cessation
- 1996-01-09 DK DK96300197T patent/DK0721782T3/da active
2000
- 2000-11-07 GR GR20000402462T patent/GR3034773T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0721782A2 (en)	1996-07-17
DE69609739D1 (de)	2000-09-21
GR3034773T3 (en)	2001-02-28
DE69609739T2 (de)	2001-04-12
ES2150631T3 (es)	2000-12-01
PT721782E (pt)	2001-02-28
GB9500788D0 (en)	1995-03-08
EP0721782B1 (en)	2000-08-16
ATE195427T1 (de)	2000-09-15
EP0721782A3 (en)	1997-04-16

Publication	Publication Date	Title
MX9803290A (es)	1998-09-30	Composiciones de la vacuna influenza.
BR9906927A (pt)	2001-11-20	Proteìnas de neisseria meningitidis
AU3526995A (en)	1996-04-26	Vaccine compositions
FI913820A0 (fi)	1991-08-12	Traodlikt hemagglutinin fraon bordetella pertussis som baerarmolekyl foer konjugatvaccin.
IL118579A0 (en)	1996-10-16	Immunological combination compositions and methods
ES2139879T3 (es)	2000-02-16	Adyuvante de la mucosa no toxico.
AU4267093A (en)	1993-11-29	Vaccine compositions for mucosal delivery
GB9401987D0 (en)	1994-03-30	Modified nucleic acid
DK0725653T3 (da)	2004-10-11	Vaccinepræparater
NZ331557A (en)	1999-11-29	Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
DE69018926D1 (de)	1995-06-01	Vakzine gegen Bordetella.
ATE195427T1 (de)	2000-09-15	Pertussistoxin enthaltender influenzaimpfstoff
FR2693655B1 (fr)	1994-10-14	Vaccin antirabique avirulent.
NL300336I1 (nl)	2008-04-01	Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
CA2388054A1 (en)	2001-05-25	Compositions and methods for stimulating an immune response against infectious agents
BR0013574A (pt)	2002-06-11	Antìgeno vacina de moraxella
BR9905780A (pt)	2001-04-24	Antìgenos vacinais de leptospira para prevenção da laptospirose
FR2633832B1 (fr)	1991-05-31	Vaccin antirabique avirulent
EP0563288A4 (en)	1994-08-24	Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines